Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Taku Ikenogami

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Bioorganic & Medicinal Chemistry Letters|November 17, 2018
Discovery of a novel azetidine scaffold for colony stimulating factor-1 receptor (CSF-1R) Type II inhibitors by the use of docking modelsKazutaka Ikegashira, Taku Ikenogami, Takayuki Yamasaki, et al.
Bioorganic & Medicinal Chemistry Letters|February 14, 2019
Optimization of an azetidine series as inhibitors of colony stimulating factor-1 receptor (CSF-1R) Type II to lead to the clinical candidate JTE-952Kazutaka Ikegashira, Taku Ikenogami, Takayuki Yamasaki, et al.
Bioorganic & Medicinal Chemistry Letters|December 10, 2025
A potent and selective RORγ inhibitor for the treatment of autoimmune diseasesTaku Ikenogami, Masahiro Yokota, Shingo Fujioka, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of a potent and short-acting oral calcilytic with a pulsatile secretion of parathyroid hormoneYuko Shinagawa, Teruhiko Inoue, Takeo Katsushima, et al.
Journal of Medicinal Chemistry|February 19, 2019
Discovery of Second Generation RORγ Inhibitors Composed of an Azole ScaffoldMasayuki Kotoku, Takaki Maeba, Shingo Fujioka, et al.
Journal of Medicinal Chemistry|July 18, 2025
A Concise and Modular Approach to Generate Novel RORγ AgonistsShunichi Fukuda, Taku Ikenogami, Kazuki Otake, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Bioorganic & Medicinal Chemistry Letters|November 17, 2018
Discovery of a novel azetidine scaffold for colony stimulating factor-1 receptor (CSF-1R) Type II inhibitors by the use of docking modelsKazutaka Ikegashira, Taku Ikenogami, Takayuki Yamasaki, et al.
Bioorganic & Medicinal Chemistry Letters|February 14, 2019
Optimization of an azetidine series as inhibitors of colony stimulating factor-1 receptor (CSF-1R) Type II to lead to the clinical candidate JTE-952Kazutaka Ikegashira, Taku Ikenogami, Takayuki Yamasaki, et al.
Bioorganic & Medicinal Chemistry Letters|December 10, 2025
A potent and selective RORγ inhibitor for the treatment of autoimmune diseasesTaku Ikenogami, Masahiro Yokota, Shingo Fujioka, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of a potent and short-acting oral calcilytic with a pulsatile secretion of parathyroid hormoneYuko Shinagawa, Teruhiko Inoue, Takeo Katsushima, et al.
Journal of Medicinal Chemistry|February 19, 2019
Discovery of Second Generation RORγ Inhibitors Composed of an Azole ScaffoldMasayuki Kotoku, Takaki Maeba, Shingo Fujioka, et al.
Journal of Medicinal Chemistry|July 18, 2025
A Concise and Modular Approach to Generate Novel RORγ AgonistsShunichi Fukuda, Taku Ikenogami, Kazuki Otake, et al.
Pageof 1